Compounded "semaglutide" is not FDA approved semaglutide.com The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157 Banned: Key Facts on the Latest FDA Decision Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review